(Q46427167)

English

Mycophenolate sodium does not reduce the incidence of GI adverse events compared with mycophenolate mofetil

scientific article published in May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15816903

Mycophenolate sodium does not reduce the incidence of GI adverse events compared with mycophenolate mofetil (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15816903

author name string

Herwig-Ulf Meier-Kriesche

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15816903

Neal M Davies

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15816903

Josep Grinyó

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15816903

Robert Heading

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15816903

Richard Mamelok

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15816903

Peter Wijngaard

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15816903

Michael Oellerich

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15816903

Bart Maes

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15816903

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15816903

American Journal of Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15816903

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15816903

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15816903

1164; author reply 1165-6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15816903

Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00778.X

21 January 2018

Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00778.X

21 January 2018

Reports of large immunosuppression trials in kidney transplantation: room for improvement.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00778.X

21 January 2018

Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00778.X

21 January 2018

Identifiers

10.1111/J.1600-6143.2005.00778.X

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15816903

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15816903

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46427167&oldid=2111087124"